NCT07281599Recruiting
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Source: ClinicalTrials.gov · Last updated 24 Jul 2026
Brief summary (registry, in English)
The EQUIP Study is testing whether high-risk human papillomavirus (hrHPV), the virus that causes most cervical cancers, can be accurately detected from menstrual blood collected at home. People who have been referred for colposcopy after an abnormal Pap or hrHPV test will use the Q-Pad Kit during their period to collect menstrual samples on a special menstrual pad and mail them to a central laboratory for hrHPV testing. The same participants will have a standard cervical sample collected for routine hrHPV testing and will undergo colposcopy as part of their usual care. By comparing hrHPV results from menstrual samples with results from cervical samples and biopsy findings, the study will evaluate how well the Q-Pad hrHPV Test System detects cervical precancer and will also assess how easy and acceptable it is for participants to use this at-home collection method.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 450 (estimated)
- First submitted
- 3 Dec 2025
- Start date
- 1 Dec 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Qurasense
- Diseases
- Cervical cancer
- NCT number
- NCT07281599
What you commit to
- Study type: Interventional
- Planned participants: 450
- From 1 Dec 2025 to the primary completion date, 31 Dec 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- You had treatment for cervical pre-cancer (CIN2+)-such as LEEP, cone, or ablation-within the last 12 months.
Other
- You are pregnant or think you might be.
- You are unwilling or unable to use the two Q-Pads and mail them back (mailing costs are covered).
- You have already joined this study or are in another cervical-screening / HPV study right now.
Who the study is looking for
- You are 25 years old or older and have an intact cervix.
- You were referred for a colposcopy after an abnormal Pap or HPV screen.
- Your periods come regularly-about every 21-35 days.
- You own a smartphone, have an email address, and can read the Qvin app instructions in English.
- You are willing to sign the consent form (electronically).
- You agree to use a condom for any vaginal intercourse or shared penetrative toy use from Q-Pad collection until the colposcopy visit if engaging with a new sexual partner during this period.
Age in the registry: 25 years to - · Sex: Female · Accepts healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Planned Parenthood of Greater Ohio (PPGOH) Coordinator of this site? Confirm its status | Akron | United States | Recruiting |
| Planned Parenthood North Central States Coordinator of this site? Confirm its status | Minneapolis | United States | Recruiting |
| Planned Parenthood of Southern New England Coordinator of this site? Confirm its status | New Haven | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.